Randomized Trial Comparing Gastric Bypass With and Without Cholecystectomy
Pilot Open Randomized Controlled Trial Comparing Patients Undergoing Robotic Gastric Bypass With or Without Concomitant Cholecystectomy
1 other identifier
interventional
90
1 country
1
Brief Summary
The main objective of this pilot study is to show feasibility to collect peri-operative and postoperative clinical data of the study group of gastric bypass without cholecystectomy compared with the control group of gastric bypass with cholecystectomy. Our hypothesis is that the approach without cholecystectomy would be superior in terms of a decrease of perioperative adverse events and postoperative complications, as well as lenght of operation, lenght of hospital stay, overall costs with a very low risk of biliary complication in the follow up. These findings could be helpful to build a baseline for a future randomized controlled multicenter study allowing significance of these results and help orientate surgeons towards best surgical care of the gallbladder with confirmed absence of stones in the obese patient undergoing gastric bypass.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 18, 2018
CompletedFirst Submitted
Initial submission to the registry
March 24, 2020
CompletedFirst Posted
Study publicly available on registry
March 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedMarch 27, 2020
March 1, 2020
2 years
March 24, 2020
March 24, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Composite endpoint consisting of: a.: intraoperative adverse events b.: postoperative complications
Primary endpoint: 1\. composite endpoint consisting of: 1. : intraoperative adverse events (common bile duct lesion, lesion of liver, lesion of digestive tract, bleeding, conversion). 2. : postoperative complications according to Dindo/Clavien Classification
within 30 days after intervention
Secondary Outcomes (10)
Intraoperative adverse events in detail
day of operation
2. Morbidity and mortality
18 months
operation time
day of operation
hospital stay
6 months
gallstones
18 months
- +5 more secondary outcomes
Study Arms (2)
Study Arm without cholecystectomy
OTHERStudy Arm: Patients with gastric bypass without concomitant cholecystectomy
Control Arm with cholecystectomy
OTHERControl Arm: Patients with gastric bypass with concomitant cholecystectomy
Interventions
Study Arm: robotic gastric bypass without cholecystectomy Control Arm: robotic gastric bypass with cholecystectomy
Eligibility Criteria
You may qualify if:
- Patients must meet the criteria of the Swiss society for the study of morbid obesity (SMOB) to undergo gastric bypass (19):
- BMI ≥ 35 kg/m2
- Having followed a 2 year adequate program of weight loss without success or a 1 year program in case of "superobesity" (BMI ≥ 50 kg/m2)
- Consent to multidisciplinary follow up for 5 years
- Preoperative ultrasound without presence of gallstones or polyps
- Age ≥ 18 years
You may not qualify if:
- Patients which have a contra-indication for gastric bypass according to the criteria of the Swiss society for the study of morbid obesity (SMOB) to undergo gastric bypass (19):
- Pregnancy
- Kidney failure (creatinine ≥ 300mmol/l, GFR \< 30ml/min) without dialysis
- Cirrhosis Child B/C
- Ulcerative Colitis
- Pulmonary embolism or deep venous thrombosis during the last 6 months
- Psychiatric contra indications
- Drug abuse (alcohol, cannabis, opioids) during the last 6 months
- Presence of gallstones on preoperative Ultrasound (which will require concomitant cholecystectomy)
- Patients with clinical diagnosis of cholecystitis defined as right upper quadrant abdominal pain, radiological signs of cholecystits and laboratory signs of infection or gallstone migration, defined as right upper quadrant and abnormal liver function tests (any increase in AST, ALT, alkaline Phosphatase, GGT and/or bilirubin).
- Previous bariatric surgery other than gastric banding
- Open bypass procedure
- Medical conditions preventing informed consent
- Preoperative routine work-up includes a physical examination, vital parameters, laboratory analyses (hematology, chemistry and HbA1c), sleep apnea evaluation with Polygraphia, abdominal ultrasound, endoscopy of the stomach, pulmonary function, preoperative anesthesia consultation and psychological evaluation.
- The results of these routine tests will be used to assess the patients'eligiibility to participate to the proposed pilot study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Visceral Surgery, Department of Surgery, University Hospital Geneva
Geneva, 1206, Switzerland
Related Publications (12)
Mason EE, Renquist KE. Gallbladder management in obesity surgery. Obes Surg. 2002 Apr;12(2):222-9. doi: 10.1381/096089202762552395.
PMID: 11975217RESULTSchmidt JH, Hocking MP, Rout WR, Woodward ER. The case for prophylactic cholecystectomy concomitant with gastric restriction for morbid obesity. Am Surg. 1988 May;54(5):269-72.
PMID: 3364862RESULTShiffman ML, Sugerman HJ, Kellum JM, Brewer WH, Moore EW. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol. 1991 Aug;86(8):1000-5.
PMID: 1858735RESULTEverhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med. 1993 Nov 15;119(10):1029-35. doi: 10.7326/0003-4819-119-10-199311150-00010.
PMID: 8214980RESULTWorni M, Guller U, Shah A, Gandhi M, Shah J, Rajgor D, Pietrobon R, Jacobs DO, Ostbye T. Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008. Obes Surg. 2012 Feb;22(2):220-9. doi: 10.1007/s11695-011-0575-y.
PMID: 22183984RESULTPatel KR, White SC, Tejirian T, Han SH, Russell D, Vira D, Liao L, Patel KB, Gracia C, Haigh P, Dutson E, Mehran A. Gallbladder management during laparoscopic Roux-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary. Am Surg. 2006 Oct;72(10):857-61.
PMID: 17058721RESULTWeinsier RL, Ullmann DO. Gallstone formation and weight loss. Obes Res. 1993 Jan;1(1):51-6. doi: 10.1002/j.1550-8528.1993.tb00008.x.
PMID: 16350561RESULTWudel LJ Jr, Wright JK, Debelak JP, Allos TM, Shyr Y, Chapman WC. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res. 2002 Jan;102(1):50-6. doi: 10.1006/jsre.2001.6322.
PMID: 11792152RESULTWarschkow R, Tarantino I, Ukegjini K, Beutner U, Guller U, Schmied BM, Muller SA, Schultes B, Thurnheer M. Concomitant cholecystectomy during laparoscopic Roux-en-Y gastric bypass in obese patients is not justified: a meta-analysis. Obes Surg. 2013 Mar;23(3):397-407. doi: 10.1007/s11695-012-0852-4.
PMID: 23315094RESULTVillegas L, Schneider B, Provost D, Chang C, Scott D, Sims T, Hill L, Hynan L, Jones D. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg. 2004 Jan;14(1):60-6. doi: 10.1381/096089204772787301.
PMID: 14980035RESULTTucker ON, Fajnwaks P, Szomstein S, Rosenthal RJ. Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery? Surg Endosc. 2008 Nov;22(11):2450-4. doi: 10.1007/s00464-008-9769-3. Epub 2008 Feb 21.
PMID: 18288531RESULTBuchs NC, Morel P, Azagury DE, Jung M, Chassot G, Huber O, Hagen ME, Pugin F. Laparoscopic versus robotic Roux-en-Y gastric bypass: lessons and long-term follow-up learned from a large prospective monocentric study. Obes Surg. 2014 Dec;24(12):2031-9. doi: 10.1007/s11695-014-1335-6.
PMID: 24962109RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Minoa Jung, Dr
Visceral Surgery, Department of Surgery, University Hospital of Geneva
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.med.
Study Record Dates
First Submitted
March 24, 2020
First Posted
March 27, 2020
Study Start
July 18, 2018
Primary Completion
August 1, 2020
Study Completion
March 1, 2022
Last Updated
March 27, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share